Stay updated on TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.2 to v3.5.3. This indicates a small update to the study record metadata.
    Difference
    0.1%
    Check dated 2026-04-30T14:31:29.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.5.2 has been added and v3.5.0 removed, indicating a minor version patch to the site.
    Difference
    0.1%
    Check dated 2026-04-16T10:28:14.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-25T20:11:15.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:44:33.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    New site revision tag v3.4.2 is now shown; the older government funding status notices have been removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:31:06.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:17:01.000Z thumbnail image

Stay in the know with updates to TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.